SCHEMBL3884902

SCHEMBL3884902

O=C(O)CCc1ccc(OC2CCCCCC2)c(-c2ccc3[nH]ncc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 7/20 0.48
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
S1PR1 P21453 2/20 0.44
BCL9 O00512 1/20 0.40
CTNNB1 P35222 1/20 0.40
MAPK14 Q16539 1/20 0.40
TRPA1 O75762 2/20 0.39
CPT2 P23786 1/20 0.39
CPT1A P50416 1/20 0.39
S1PR3 Q99500 1/20 0.39
S1PR5 Q9H228 1/20 0.39
CDC7 O00311 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
ROCK2 O75116 2/20 0.38
CCR2 P41597 2/20 0.38
ROCK1 Q13464 2/20 0.38
FABP4 P15090 1/20 0.38
CTSC P53634 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3881066 1.00 FFAR4 (0.48) FFAR4THRATHRBS1PR1BCL9
SCHEMBL3681143 0.99 FFAR4 (0.48) FFAR4THRATHRBS1PR1BCL9
SCHEMBL3883049 0.91 FFAR4 (0.48) FFAR4THRATHRBS1PR1BCL9
SCHEMBL3881928 0.90 MAPK14 (0.42) FFAR4S1PR1BCL9CTNNB1MAPK14
SCHEMBL3882064 0.90 MAPK14 (0.42) FFAR4S1PR1BCL9CTNNB1MAPK14
SCHEMBL3679980 0.89 MAPK14 (0.43) FFAR4S1PR1BCL9CTNNB1MAPK14
SCHEMBL3882442 0.88 THRA (0.46) FFAR4THRATHRBS1PR1MAPK14
SCHEMBL3883888 0.87 THRA (0.44) FFAR4THRATHRBS1PR1MAPK14
SCHEMBL3882061 0.87 FFAR4 (0.45) FFAR4CTNNB1TRPA1CPT2CPT1A
SCHEMBL3882083 0.85 THRA (0.48) FFAR4THRATHRBMAPK14TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR4 115/4885THRA 1720/4885THRB 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.